Skip to main content
Year archive

Leadway Technology Investment Group Limited — 2023 filings

All 85 regulatory filings released by Leadway Technology Investment Group Limited (2086) in 2023, sourced directly from the official regulator.

85 Filings
2023 Period
2023 filings (85)
Filing Released Lang
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-12-29 English
Discloseable Transaction - Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.
Capital/Financing Update
2023-12-29 English
Reply Form - Election as to Means of Receipt of Corporate Communications
Regulatory Filings
2023-12-29 English
First Letter - Election as to Means of Receipt of Corporate Communications
Regulatory Filings
2023-12-29 English
Election of Means of Receipt of Corporate Communications
Regulatory Filings
2023-12-29 English
CHANGE OF PRINCIPAL SHARE REGISTRAR AND TRANSFER AGENT IN THE CAYMAN ISLANDS AND CHANGE OF REGISTERED ADDRESS
Regulatory Filings
2023-12-22 English
Potential Acquisition of 65% Equity Interest in Jiangxi Qingchun Kangyuan Pharmaceutical Co., Ltd.
Capital/Financing Update
2023-12-13 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-12-11 English
Connected Transaction - Formation of Limited Partnership Fund
Capital/Financing Update
2023-12-11 English
Poll Result of the Extraordinary General Meeting held on 5 December 2023
Declaration of Voting Results & Voting Rights Announcements
2023-12-05 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 NOVEMBER 2023
Regulatory Filings
2023-12-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 November 2023
Regulatory Filings
2023-12-01 English
Change of Deadline for Lodging of the Form of Proxy for the Extraordinary General Meeting to be held on 5 December 2023
Proxy Solicitation & Information Statement
2023-11-13 English
Notice of Extraordinary General Meeting
AGM Information
2023-11-09 English
Form of Proxy for Extraordinary General Meeting to be held on 5 December 2023
Proxy Solicitation & Information Statement
2023-11-09 English
Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary
Regulatory Filings
2023-11-09 English
Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd. and Notice of Extraordinary
Proxy Solicitation & Information Statement
2023-11-09 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 OCTOBER 2023
Regulatory Filings
2023-11-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 October 2023
Regulatory Filings
2023-11-01 English
Unaudited Financial Results for the nine months ended 30 September 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report 9M 2023
2023-10-30 English
Discloseable and Connected Transaction - Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd.
Capital/Financing Update
2023-10-10 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 SEPTEMBER 2023
Regulatory Filings
2023-10-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2023
Regulatory Filings
2023-10-03 English
List of Directors and their Roles and Functions
Board/Management Information
2023-09-29 English
Change of Executive Director and General Manager and Change of Authorised Representative
Board/Management Information
2023-09-29 English
2023 Interim Report
Interim / Quarterly Report H1 2023
2023-09-19 English
Interim Report 2023
Regulatory Filings
2023-09-15 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 AUGUST 2023
Share Issue/Capital Change
2023-09-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 August 2023
Regulatory Filings
2023-09-04 English
Interim Dividend for the six months ended 30 June 2023
Notice of Dividend Amount
2023-08-30 English
Announcement of Interim Results for the six months ended 30 June 2023
Interim / Quarterly Report H1 2023
2023-08-30 English
Potential Disposal of 15% Equity Interest in Tianjin Pharmaceutical Group Finance Co., Ltd. held by Tianjin Lisheng Pharmaceutical Co., Ltd.
Regulatory Filings
2023-08-25 English
Unaudited Financial Results for the six months ended 30 June 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report H1 2023
2023-08-25 English
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED 30 JUNE 2023
Interim / Quarterly Report H1 2023
2023-08-23 English
Date of Board Meeting
Regulatory Filings
2023-08-18 English
PROFIT WARNING
Earnings Release H1 2023
2023-08-11 English
Discloseable Transacttion - Resumption of the Properties held by Tianjin Lisheng Pharmaceutical Co., Ltd.
Regulatory Filings
2023-08-10 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-10 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-08-09 English
An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section
Regulatory Filings
2023-08-03 English
Connected Transaction - Subscription of Wealth Management Product
Capital/Financing Update
2023-08-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JULY 2023
Regulatory Filings
2023-08-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2023
Regulatory Filings
2023-08-01 English
Potential Discloseable Transaction - Resumption of the Properties held by Tianjin Lisheng Pharmaceutical Co., Ltd.
Regulatory Filings
2023-07-26 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 JUNE 2023
Regulatory Filings
2023-07-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2023
Regulatory Filings
2023-07-03 English
List of Directors and their Roles and Functions
Board/Management Information
2023-06-21 English
Poll Results of the Annual General Meeting held on 21 June 2023, Retirement of Directors and Change in Composition of Board Committees
Declaration of Voting Results & Voting Rights Announcements
2023-06-21 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MAY 2023
Major Shareholding Notification
2023-06-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2023
Regulatory Filings
2023-06-01 English
SECOND AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2023-05-24 English
POLL RESULTS OF ANNUAL GENERAL MEETING HELD ON 24 MAY 2023
Declaration of Voting Results & Voting Rights Announcements
2023-05-24 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 30 APRIL 2023
Regulatory Filings
2023-05-02 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2023
Regulatory Filings
2023-05-02 English
Unaudited Financial Results for the three months ended 31 March 2023 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Interim / Quarterly Report Q1 2023
2023-04-27 English
Notice of Annual General Meeting
AGM Information
2023-04-26 English
Form of Proxy for Annual General Meeting to be held on 21 June 2023
AGM Information
2023-04-26 English
General Mandates to Issue Shares and to Buy Back Shares, Declaration of Final Dividend, Re-election of Directors and Notice of Annual General Meeting
AGM Information
2023-04-26 English
Annual Report 2022
Annual Report FY 2022
2023-04-26 English
FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING (or at any adjournment thereof)
AGM Information
2023-04-20 English
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF THE RETIRING DIRECTORS AND PROPOSED ADOPTION OF AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION AND
Proxy Solicitation & Information Statement
2023-04-20 English
NOTICE OF ANNUAL GENERAL MEETING
AGM Information
2023-04-20 English
Annual Report 2022
Regulatory Filings
2023-04-20 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 MARCH 2023
Regulatory Filings
2023-04-03 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2023
Regulatory Filings
2023-04-03 English
List of Directors and their Roles and Functions
Board/Management Information
2023-03-30 English
Change of Directors and Change in Composition of Board Committees
Board/Management Information
2023-03-30 English
Terms of Reference of the Remuneration Committee
Remuneration Information
2023-03-30 English
Final Dividend for the year ended 31 December 2022
Notice of Dividend Amount
2023-03-30 English
Announcement of Final Results for the year ended 31 December 2022
Annual Report FY 2022
2023-03-30 English
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2022
Annual Report FY 2022
2023-03-29 English
PROPOSED ADOPTION OF THE AMENDED AND RESTATED MEMORANDUM AND ARTICLES OF ASSOCIATION
Governance Information
2023-03-29 English
Audited Financial Results for the year ended 31 December 2022 of Tianjin Lisheng Pharmaceutical Co., Ltd.
Annual Report FY 2022
2023-03-23 English
POSITIVE PROFIT ALERT
Earnings Release FY 2022
2023-03-21 English
Date of Board Meeting
Regulatory Filings
2023-03-17 English
NOTICE OF BOARD MEETING
Regulatory Filings
2023-03-14 English
Profit Warning
Regulatory Filings
2023-03-03 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 28 FEBRUARY 2023
Regulatory Filings
2023-03-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 28 February 2023
Regulatory Filings
2023-03-01 English
Overseas Regulatory Announcement
Earnings Release FY 2022
2023-02-27 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 JANUARY 2023
Regulatory Filings
2023-02-01 English
Announcement Pursuant to Rule 13.18 of the Listing Rules
Capital/Financing Update
2023-02-01 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2023
Regulatory Filings
2023-02-01 English
MONTHLY RETURN OF EQUITY ISSUER ON MOVEMENTS IN SECURITIES FOR THE MONTH ENDED 31 DECEMBER 2022
Regulatory Filings
2023-01-04 English
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2022
Regulatory Filings
2023-01-03 English